Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 2Urinary Bladder Neoplasms 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1Myelodysplastic Syndromes 1Metabolism, Inborn Errors 1Lymphoma, Non-Hodgkin 1Liposarcoma 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Immunologic Deficiency Syndromes 1Hemoglobinopathies 1Graft vs Host Disease 1Disease Progression 1Congenital Bone Marrow Failure Syndromes 1Carcinoma in Situ 1Bone Marrow Failure Disorders 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Gemcitabine 9Docetaxel 5Mitomycin 4erdafitinib 3durvalumab 3Cystoscopy 3disitamab vedotin 2BCG Vaccine 25-aminolevulinic acid hexyl ester 2tremelimumab 1tislelizumab 1monalizumab 1dodecyl maltoside 1chondroitin sulfate, sodium hyaluronate drug combination 1bicalutamide 1Urine Specimen Collection 1Transurethral Resection of Bladder 1Therapeutic Uses 1Surveys and Questionnaires 1Saline Solution 1Patient Discharge 1Paclitaxel 1Nonsteroidal Anti-Androgens 1Monatide (IMS 3015) 1Mitozytrex 1Metformin 1Magnetic Resonance Spectroscopy 1Laser Therapy 1Hyaluronic Acid 1House Calls 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Non-Muscle Invasive Bladder Neoplasms × Clinical Trials, Phase I as Topic × Clear all
NCT04752722 2026-04-30

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

enGene, Inc.

Phase 1/2 Recruiting
350 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ

Data powered by HemOnc (CC BY 4.0) Colophon âš¡